TY - JOUR
T1 - The Evolving Landscape of Discrete Choice Experiments in Health Economics
T2 - A Systematic Review
AU - Nouwens, Sven Petrus Henricus
AU - Marceta, Stella Maria
AU - Bui, Michael
AU - van Dijk, Daisy Maria Alberta Hendrika
AU - Groothuis-Oudshoorn, Catharina Gerarda Maria
AU - Veldwijk, Jorien
AU - van Til, Janine Astrid
AU - de Bekker-Grob, Esther Wilhelmina
N1 - Publisher Copyright: © The Author(s) 2025.
PY - 2025/5/21
Y1 - 2025/5/21
N2 - Introduction: Stakeholder preference evaluations are increasingly emphasized in healthcare policy and health technology assessment. Discrete choice experiments (DCEs) are the most common method for quantifying preferences among patients, the public, and healthcare professionals. While prior reviews (1990–2017) have examined DCE trends, no comprehensive synthesis exists for studies published since 2018. This updated review (2018–2023) provides critical insights into evolving methodologies and global trends in health-related DCEs. Methods: A systematic search (2018–2023) of Medline, Embase, and Web of Science identified relevant studies. Studies were screened for inclusion and data were extracted, including details on DCE design and analysis. To enable trend comparisons, the search strategy and extraction items aligned with previous reviews. Results: Of 2663 identified papers, 1279 met the inclusion criteria, reflecting a significant rise in published DCEs over time. DCEs were conducted globally, with a remarkable increase in publications from Asia and Africa compared with previous reviews. Experimental designs and econometric models have advanced, continuing prior trends. Notably, most recent DCEs were administered online. Discussion: The rapid growth of DCE applications underscores their importance in health research. While the methodology is advancing rapidly, it is crucial that researchers provide full transparency in reporting their methods, particularly in detailing experimental designs and validity tests, which are too often overlooked. Key recommendations include improving reporting of experimental designs, applying validity tests, following good practices for presenting benefit–risk attributes, and adopting open science practices. Ensuring methodological rigor will maximize the impact and reproducibility of DCE research in health economics.
AB - Introduction: Stakeholder preference evaluations are increasingly emphasized in healthcare policy and health technology assessment. Discrete choice experiments (DCEs) are the most common method for quantifying preferences among patients, the public, and healthcare professionals. While prior reviews (1990–2017) have examined DCE trends, no comprehensive synthesis exists for studies published since 2018. This updated review (2018–2023) provides critical insights into evolving methodologies and global trends in health-related DCEs. Methods: A systematic search (2018–2023) of Medline, Embase, and Web of Science identified relevant studies. Studies were screened for inclusion and data were extracted, including details on DCE design and analysis. To enable trend comparisons, the search strategy and extraction items aligned with previous reviews. Results: Of 2663 identified papers, 1279 met the inclusion criteria, reflecting a significant rise in published DCEs over time. DCEs were conducted globally, with a remarkable increase in publications from Asia and Africa compared with previous reviews. Experimental designs and econometric models have advanced, continuing prior trends. Notably, most recent DCEs were administered online. Discussion: The rapid growth of DCE applications underscores their importance in health research. While the methodology is advancing rapidly, it is crucial that researchers provide full transparency in reporting their methods, particularly in detailing experimental designs and validity tests, which are too often overlooked. Key recommendations include improving reporting of experimental designs, applying validity tests, following good practices for presenting benefit–risk attributes, and adopting open science practices. Ensuring methodological rigor will maximize the impact and reproducibility of DCE research in health economics.
UR - http://www.scopus.com/inward/record.url?scp=105006623277&partnerID=8YFLogxK
U2 - 10.1007/s40273-025-01495-y
DO - 10.1007/s40273-025-01495-y
M3 - Review article
C2 - 40397369
AN - SCOPUS:105006623277
SN - 1170-7690
JO - PharmacoEconomics
JF - PharmacoEconomics
M1 - n71
ER -